Findings

What do systematic reviews say?

36 questions · 36 findings · 4 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 7 · 19.4%GRADE not reported 1 · 2.8%Very low 9 · 25%Low 16 · 44.4%Moderate 0 · 0%High 3 · 8.3%

SSRIs or SNRIs vs placebo

Headache intensity (mean score) · patients with tension‐type headache

1 finding from 1 review

Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the… 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Low

SSRIs or SNRIs vs placebo

Headache duration (hours) · patients with tension‐type headache

1 finding from 1 review

Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the… 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Low

SSRIs or SNRIs vs placebo

Symptomatic/analgesic medication use for acute headache attacks · patients with tension‐type headache

1 finding from 1 review

Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the… 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 118 participants
Low

SSRIs or SNRIs vs placebo

Headache index · patients with tension‐type headache

1 finding from 1 review

Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the… 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 128 participants
Very low

SSRIs or SNRIs vs placebo

Quality of life · patients with tension‐type headache

The review found no eligible studies for this question.

1 finding from 1 review

Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the… 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

SSRIs or SNRIs vs placebo

Withdrawals due to adverse events · patients with tension‐type headache

It is very uncertain whether SSRIs or SNRIs changes withdrawals due to adverse events compared with placebo (very low certainty).

1 finding from 1 review

Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the… 2015 · Cochrane Headline outcomes only
OR 3.72 [0.79, 17.53]
3 studies · 190 participants
Very low

SSRIs or SNRIs vs other antidepressants

Headache (frequency) · patients with tension‐type headache

1 finding from 1 review

Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the… 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 152 participants
Very low

SSRIs or SNRIs vs other antidepressants

Headache intensity (mean score) · patients with tension‐type headache

1 finding from 1 review

Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the… 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 152 participants
Very low

SSRIs or SNRIs vs placebo or no treatment

Improvement in vertigo · adults with PPPD

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

SSRIs or SNRIs vs placebo or no treatment

Change in vertigo · adults with PPPD

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

SSRIs or SNRIs vs placebo or no treatment

Serious adverse events · adults with PPPD

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for persistent postural‐perceptual dizziness (PPPD) 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Selective serotonin reuptake inhibitors vs SNRIs

Failure to respond at endpoint (6‐12 weeks) · adults with panic disorder

SSRIs showed no clear difference in failure to respond compared with SNRIs (high certainty).

1 finding from 1 review

Antidepressants and benzodiazepines for panic disorder in adults 2016 · Cochrane Headline outcomes only
RR 0.96 [0.75, 1.23]
2 studies · 991 participants
High

Selective serotonin reuptake inhibitors vs SNRIs

Leaving the study early · adults with panic disorder

SSRIs showed no clear difference in total number of dropouts compared with SNRIs (low certainty).

1 finding from 1 review

Antidepressants and benzodiazepines for panic disorder in adults 2016 · Cochrane Headline outcomes only
RR 1.11 [0.74, 1.65]
2 studies · 991 participants
Low

Selective serotonin reuptake inhibitors vs SNRIs

Failure to remit at endpoint · adults with panic disorder

SSRIs showed no clear difference in failure to remit compared with SNRIs (high certainty).

1 finding from 1 review

Antidepressants and benzodiazepines for panic disorder in adults 2016 · Cochrane Headline outcomes only
RR 1.05 [0.91, 1.21]
2 studies · 991 participants
High

Selective serotonin reuptake inhibitors vs SNRIs

panic symptoms · adults with panic disorder

1 finding from 1 review

Antidepressants and benzodiazepines for panic disorder in adults 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 945 participants
High

Selective serotonin reuptake inhibitors vs SNRIs

Withdrawals due to adverse events · adults with panic disorder

SSRIs showed no clear difference in number of dropouts due to adverse effects compared with SNRIs (low certainty).

1 finding from 1 review

Antidepressants and benzodiazepines for panic disorder in adults 2016 · Cochrane Headline outcomes only
RR 1.86 [0.49, 7.05]
2 studies · 991 participants
Low